Reata Pharmaceuticals logo
Reata Pharmaceuticals RETA
$ 172.36 0.0%

Quarterly report 2023-Q1
added 05-10-2023

report update icon

Reata Pharmaceuticals Cash and Cash Equivalents 2011-2024 | RETA

Annual Cash and Cash Equivalents Reata Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
42.3 M 590 M 818 M 664 M 338 M 130 M 84.7 M 42 M 87.8 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
818 M 42 M 311 M

Quarterly Cash and Cash Equivalents Reata Pharmaceuticals

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
84.9 M 42.3 M 31.9 M 147 M 532 M 590 M 713 M 756 M 778 M 818 M 818 M 818 M 818 M 664 M 664 M 664 M 664 M 338 M 338 M 338 M 338 M 130 M 130 M 130 M 130 M 84.7 M 84.7 M 84.7 M 84.7 M 42 M 42 M 42 M - 87.8 M - - - 177 M - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
818 M 31.9 M 359 M